Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

Featured Releases

December 06, 2025 08:00 ET | Source: Costco Wholesale Canada Ltd

Canada’s Tenth Costco Business Centre is now open in East Gwillimbury

COSTCO BUSINESS CENTRE IS NOW OPEN IN EAST GWILLIMBURY - 240 JOBS CREATED, THOUSANDS OF UNIQUE ITEMS TAILORED TO BUSINESS NEEDS
Read More
December 06, 2025 07:00 ET | Source: Mutuum Finance

DeFi Crypto Mutuum Finance Prepares for 20% Price Increase as Phase 6 Nears Completion

DUBAI, United Arab Emirates, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM) is approaching a major milestone as Phase 6 of its presale nears completion, bringing the project closer to its...
Read More

December 06, 2025 08:53 ET | Source: Bragar Eagel & Squire

ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds aTyr Investors to Contact the Firm Before December 8th Regarding Their Rights

The complaint alleges defendants overstated Efzofitimod’s efficacy, hid steroid-taper issues, and inflated aTyr’s stock through these misstatements.
December 06, 2025 08:45 ET | Source: SNS Insider pvt ltd

CBD Nutraceuticals Market Projected to Reach USD 39.06 Billion by 2032 at 16.38% CAGR – SNS Insider

The Global CBD Nutraceuticals Market Growth Is Driven by the Rising Demand for Natural Wellness Products and Expanding Legalization of Hemp-derived CBD.
December 06, 2025 08:34 ET | Source: The Rosen Law Firm PA

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages StubHub Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STUB

NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of StubHub Holdings, Inc. (NYSE: STUB) pursuant and/or...
December 06, 2025 08:30 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting

Adaptive announces deep interventional use of clonoSEQ across abstracts at ASH
December 06, 2025 08:30 ET | Source: SNS Insider pvt ltd

Tele-intensive Care Unit Market Size to Reach USD 11.96 Billion by 2032; Growing Advancements in Technology to Propel Market Growth Globally – SNS Insider

Growing adoption of AI enabled remote monitoring and strong demand for critical care efficiency propel tele-intensive care unit market worldwide.
December 06, 2025 08:28 ET | Source: SNS Insider pvt ltd

Lithium-ion (Li-ion) Battery Market Size to Surpass USD 250.04 Billion by 2033 | Research by SNS Insider

Global Li-Ion Battery Market Size, Share & Trends Analysis Report, By Product Type, By Application, By Region and Global Forecast for 2026-2033
December 06, 2025 08:05 ET | Source: Io Therapeutics, Inc.

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human multiple myeloma

Io Therapeutics announced at the American Society of Hematology studies of their RXR agonist IRX4204 in combination with CAR-T cells for multiple myeloma
December 06, 2025 08:05 ET | Source: Arvinas Inc.

Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition

– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial to evaluate ARV-393 plus glofitamab as a chemotherapy-free combination approach in diffuse large B-cell lymphoma...
December 06, 2025 08:00 ET | Source: Costco Wholesale Canada Ltd

Canada’s Tenth Costco Business Centre is now open in East Gwillimbury

COSTCO BUSINESS CENTRE IS NOW OPEN IN EAST GWILLIMBURY - 240 JOBS CREATED, THOUSANDS OF UNIQUE ITEMS TAILORED TO BUSINESS NEEDS
December 06, 2025 08:00 ET | Source: Beam Therapeutics

Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting

Updated Data from 31 Adult and Adolescent SCD Patients Treated with risto-cel (Formerly BEAM-101) Show Mean Hemoglobin F (HbF) Induction of >60%, Hemoglobin S (HbS) Reduction to <40%, and...

1 2 ...314375